Funder
National Science and Technology Major Project of China
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection: 2015 March. Geneva: World Health Organization; 2015.
2. Arvaniti V, D’Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139:1246–1256.e5.
3. Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521–31.
4. Sun Y, Wu X, Zhou J, et al. Persistent low level of hepatitis b virus promotes fibrosis progression during therapy. Clin Gastroenterol Hepatol. 2020;18:2582–2591.e6.
5. Yuen MF, Wong DK, Fung J, et al. HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology. 2008;135:1192–9.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献